Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
  • DSP Mutual Fund
you are here: HomeNewsThyrocare
thyrocare
Jump to
  • Stock Market Live: Covid Fears Hurting Markets. Will The Selloff Continue? RIL, Thyrocare In Focus Dec 23, 2022 08:30 AM IST

    Stock Market Live: Covid Fears Hurting Markets. Will The Selloff Continue? RIL, Thyrocare In Focus

    Indian markets logged a third straight day of losses amid renewed Covid fears and RBI minutes that indicated that Governor Shaktikanta Das is not in favour of a pause in rate hikes just yet. Will the selloff continue as we step into the new year? Hemang Jani of Motilal Oswal Financial Services shares his outlook on the market going forward. Also catch NeoTrader’s Raja Venkatraman share his thoughts on stocks like RIL, Thyrocare and RailTel.

  • Stock Market Live: Diagnostics Stocks Back In Limelight Amid Covid Fears. Can The Momentum Sustain? Dec 22, 2022 08:53 AM IST

    Stock Market Live: Diagnostics Stocks Back In Limelight Amid Covid Fears. Can The Momentum Sustain?

    Diagnostics stocks saw a smart surge amid renewed fears of Covid outbreaks globally. Shares of Dr Lal PathLabs, Metropolis Healthcare, Vijaya Diagnostic Centre and Thyrocare rallied up to 6% in yesterday as investors see brighter prospects for diagnostics and healthcare businesses amid Covid scare. Catch Santosh Nair's thoughts on whether this rally will sustain and also catch his views on Sula Vineyards which makes its debut on the stock exchanges today and Lupin.

  • Discovery series: Is it time to start looking at this quality diagnostic service? Oct 04, 2022 04:26 PM IST

    Discovery series: Is it time to start looking at this quality diagnostic service?

    We expect an earnings CAGR in mid-teens in the medium term for VDC on the back of an expansion-led volume growth in the hinterland

  • Stock Market Live: Nifty below 17,350 – more correction likely? Thyrocare, BLS and Orient Cement in focus Aug 30, 2022 08:08 AM IST

    Stock Market Live: Nifty below 17,350 – more correction likely? Thyrocare, BLS and Orient Cement in focus

    European markets were lower on Monday after US Fed Chair Jerome Powell signalled higher interest rates would likely persist in a bid to tame soaring inflation. All sectors and major bourses slipped into negative territory. Tech stocks led the losses, down over 2%. Stocks in the spotlight today – Thyrocare, Orient Cement and BLS International. On the show today we try to decode whether the current market mood is a minor hiccup in the bull run or a deeper correction awaits?

  • Thyrocare founder wants to invest 'minimum Rs 100 crore' in goat farming business Aug 28, 2022 06:12 PM IST

    Thyrocare founder wants to invest 'minimum Rs 100 crore' in goat farming business

    Realising that the idea may take many by surprise, Thyrocare founder Dr Arokiaswamy Velumani revealed that goat farming was his first failure in life and he was only 10.

  • Thyrocare unveils new brand identity with a change in logo Jun 01, 2022 10:36 AM IST

    Thyrocare unveils new brand identity with a change in logo

    Thyrocare says the new tagline “Tests you can trust” reflects the transformation of the company over the last 25 years

  • Thyrocare boss recalls how he was asked to compare himself to fallen Silicon Valley star Elizabeth Holmes Jan 05, 2022 03:45 PM IST

    Thyrocare boss recalls how he was asked to compare himself to fallen Silicon Valley star Elizabeth Holmes

    One question that Thyrocare founder Dr A Velumani strikingly remembers compared him to Elizabeth Holmes, the fallen US biotech star, who was convicted on of defrauding investors in her blood-testing start-up Theranos.

  • Dr Lal Pathlab – Suburban Diagnostic deal - a marriage made in a Petri dish Oct 28, 2021 09:20 AM IST

    Dr Lal Pathlab – Suburban Diagnostic deal - a marriage made in a Petri dish

    Inorganic growth in this sector has been the norm across the globe, and most countries in the developed world have 5-6 large players dominating the space

  • PharmEasy raises $350 million in pre-IPO round: Report Oct 18, 2021 10:40 AM IST

    PharmEasy raises $350 million in pre-IPO round: Report

    Nearly 20 senior employees bought shares worth $5 million as part of the secondary sale while early investors sold their stakes in the firm and IIFL’s tech fund has picked up some stake, the report said.

  • Vijaya Diagnostic: What does this regional player offer amid industry consolidation? Sep 15, 2021 09:34 AM IST

    Vijaya Diagnostic: What does this regional player offer amid industry consolidation?

    Going forward, technology will be the differentiator, and Vijay Diagnostic's differentiated hub- and-spoke model calls for attention

  • Trend of omni-channel transactions like PharmEasy-Thyrocare here to stay, says ace dealmaker Sourav Mallik of Kotak Jul 31, 2021 07:19 PM IST

    Trend of omni-channel transactions like PharmEasy-Thyrocare here to stay, says ace dealmaker Sourav Mallik of Kotak

    Sourav Mallik, who has over 25 years of experience in investment banking and has advised on marquee transactions like Tech Mahindra’s acquisition of Satyam, believes that the Zomato market debut has confirmed that investors have the maturity to understand and appreciate new age companies. His top sectoral picks for deal activity include the digital ecosystem, healthcare, consumer, specialty chemicals and financial services

  • Emotional Dr Velumani says he “moved fast for a change” as he sold Thyrocare to PharmEasy Jun 28, 2021 05:52 PM IST

    Emotional Dr Velumani says he “moved fast for a change” as he sold Thyrocare to PharmEasy

    Dr A Velumani and his family will sell their 66.1 percent stake in Thyrocare to PharmEasy for Rs 4,546 crore. It’s a bumper value-unlocking for the family in the best year possible for the diagnostics business during the pandemic. The need for a change and de-risking are some of the key reasons for the sale, said Dr Velumani.

  • Pharmeasy raises additional $300 million from investors, aims for IPO in 6-18 months Jun 28, 2021 12:25 PM IST

    Pharmeasy raises additional $300 million from investors, aims for IPO in 6-18 months

    Siddharth Shah, CEO, API Holdings said that once the acquisition of Thyrocare is complete, Pharmeasy will aim to have its IPO within 6 to 18 months.

  • PharmEasy to acquire 66.1% stake in Thyrocare for Rs 4,546 crore Jun 25, 2021 06:48 PM IST

    PharmEasy to acquire 66.1% stake in Thyrocare for Rs 4,546 crore

    Docon Technologies Pvt Ltd, a 100 percent subsidiary of PharmEasy's parent firm API, will be the acquirer and shall make an open offer for an additional 26 percent stake.

  • Exclusive | PharmEasy in talks to acquire Thyrocare for Rs 7,000 crore Jun 17, 2021 09:44 PM IST

    Exclusive | PharmEasy in talks to acquire Thyrocare for Rs 7,000 crore

    Online medical store PharmEasy is in advanced talks to acquire diagnostics services chain Thyrocare in a deal worth about Rs 7,000 crore, people with direct knowledge of the development told Moneycontrol. Nisha Poddar shares the details. Watch:

  • Exclusive | PharmEasy in talks to buy Thyrocare for around Rs 7,000 crore Jun 17, 2021 01:01 PM IST

    Exclusive | PharmEasy in talks to buy Thyrocare for around Rs 7,000 crore

    The deal is likely to be announced soon given the IPO timelines of PharmEasy’s parent, API Holdings, people with direct knowledge of the development said.

  • Emerging healthcare trends put diagnostics sector in a sweet spot, IIFL Sec recommends buy on Metropolis, Thyrocare Apr 22, 2021 11:15 AM IST

    Emerging healthcare trends put diagnostics sector in a sweet spot, IIFL Sec recommends buy on Metropolis, Thyrocare

    Larger players from the diagnostic sector are positioned to gain more than the smaller ones and fragmented market share is an opportunity for them to expand their share.

  • COVID Vaccine: The opportunities for investors - Part I Dec 11, 2020 08:32 AM IST

    COVID Vaccine: The opportunities for investors - Part I

    Vaccine rollout will throw up opportunities not just for the domestic pharmaceutical and healthcare industry but also the logistics value chain, right from vaccine production, delivery, storage and then the actual immunisation

  • States controlling COVID-19 testing to show lower number of cases, says Thyrocare Oct 28, 2020 12:51 PM IST

    States controlling COVID-19 testing to show lower number of cases, says Thyrocare

    In some states, Thyrocare has been told not to pick up samples, verbally, said A Velumani, CMD & CEO of Thyrocare Technologies

  • Diagnostic firms ride the COVID-19 wave, retention of business gains key Oct 14, 2020 10:22 AM IST

    Diagnostic firms ride the COVID-19 wave, retention of business gains key

    Diagnostic firms such as Dr Lal PathLabs, Thyrocare Technologies and Metropolis Healthcare rebound as COVID-19 related tests drive business growth. While non COVID-19 business is showing signs of normalisation, sustainability of recovery is key

  • One in four Indians could have been infected with the coronavirus: Dr A Velumani of Thyrocare Aug 20, 2020 04:41 PM IST

    One in four Indians could have been infected with the coronavirus: Dr A Velumani of Thyrocare

    Thyrocare’s findings are in line with government surveys done in Indian cities such as Mumbai, which showed that 57 percent of the population in its crowded slum areas had been exposed to the coronavirus.

  • May lower COVID-19 testing fee in the next 10 days: Thyrocare CEO A Velumani Apr 07, 2020 08:47 PM IST

    May lower COVID-19 testing fee in the next 10 days: Thyrocare CEO A Velumani

    The company has announced that it will conduct coronavirus testing on a zero-profit basis for the next one year.

  • Coronavirus pandemic | Thyrocare CEO Velumani says logistics is the biggest challenge for COVID-19 test kit suppliers Apr 01, 2020 02:28 PM IST

    Coronavirus pandemic | Thyrocare CEO Velumani says logistics is the biggest challenge for COVID-19 test kit suppliers

    Private lab chain Thyrocare has tied up with digital healthcare platform Practo to enable booking of COVID-19 test kits online.

  • Coronavirus pandemic | Now book a COVID-19 test online via Practo for Rs 4,500 Mar 31, 2020 07:39 PM IST

    Coronavirus pandemic | Now book a COVID-19 test online via Practo for Rs 4,500

    Patients with a valid doctor’s prescription and a requisition form filled and signed by the doctor will be allowed to opt for the test.

  • Practo ties up with Thyrocare to offer bookings of COVID-19 test on its platform Mar 28, 2020 07:53 PM IST

    Practo ties up with Thyrocare to offer bookings of COVID-19 test on its platform

    Any patient with a valid doctor’s prescription and a requisition form filled and signed by the doctor will be allowed to opt for a Covid-19 test.